A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma
A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma
Not yet recruiting · NCT07239986 · Registry updated 2025-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Phase 2 | 2025-11-20 | NCT07239986 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Broadenbio Ltd., Co. | 3 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of University of Science and Technology of China | Hefei | China | 1 |
| Zhongshan Hospital | Shanghai | China | 20 |